Insider Transactions in Q3 2022 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2022
|
Kim R Tsuchimoto Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,753
-10.6%
|
$1,753
$1.52 P/Share
|
|
Sep 30
2022
|
Kim R Tsuchimoto Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,066
+23.46%
|
-
|
|
Sep 30
2022
|
Christopher M Starr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,859
+18.18%
|
-
|
|
Sep 30
2022
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,077
-6.06%
|
$4,077
$1.52 P/Share
|
|
Sep 30
2022
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,911
+17.13%
|
-
|
|
Sep 30
2022
|
Arthur J Klausner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,859
+13.79%
|
-
|
|
Sep 30
2022
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,191
-12.7%
|
$1,191
$1.52 P/Share
|
|
Sep 30
2022
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,063
+30.23%
|
-
|
|
Sep 30
2022
|
Michael J Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,859
+1.27%
|
-
|
|
Sep 30
2022
|
Raymond Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,859
+17.09%
|
-
|